Salvage surgery for recurrent or persistent tumour after radical (chemo)radiotherapy for locally advanced non-small cell lung cancer: a systematic review.
Chris DickhoffRene H J OttenMartijn W HeymansMax DahelePublished in: Therapeutic advances in medical oncology (2018)
There are limited, low-level, heterogeneous data in support of salvage surgery after radical CRT. Based on this, perioperative mortality appears acceptable and long-term survival is possible in (highly) selected patients. In suitable patients (fit, no distant metastases, tumour appears completely resectable and preferably with confirmed viable tumour), this treatment option should be discussed in an experienced multidisciplinary lung cancer team.
Keyphrases
- end stage renal disease
- ejection fraction
- minimally invasive
- newly diagnosed
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- early stage
- heart failure
- squamous cell carcinoma
- coronary artery bypass
- locally advanced
- coronary artery disease
- patient reported outcomes
- type diabetes
- drug delivery
- photodynamic therapy
- patients undergoing
- risk factors
- artificial intelligence
- atrial fibrillation
- palliative care
- acute kidney injury
- electronic health record
- cardiovascular events
- surgical site infection
- smoking cessation
- patient reported
- free survival